Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Incidence of Invasive Aspergillosis in Allogeneic Stem Cell Transplantation Patients: an Italian Prospective Multicentre Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00838643

Enrollment

220

Registered

2009-02-06

Start date

2002-05-31

Completion date

2009-12-31

Last updated

2009-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Diseases, Invasive Aspergillosis

Keywords

allogeneic transplantation, Invasive aspergillosis

Brief summary

Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan in asymptomatic patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \> 16 years * Allogeneic HSCT for a haematological disease * Written informed consent to the study

Exclusion criteria

* Pediatric patients

Design outcomes

Primary

Measure	Time frame
Incidence of invasive aspergillosis	1 year

Secondary

Measure	Time frame
Clinical applicability of the EORTC/MSG criteria in a prospective multicenter trial	1 year

Countries

Italy

Outcome results